Acviss at The Pharma India Expo 2024
Protecting Pharmaceutical Supply Chains from Counterfeit Medicines
About the Event
Counterfeit Medicines Are a Public Health Threat
Acviss joined The Pharma India Expo 2024 to address one of the pharmaceutical industry’s most critical challenges: counterfeit medicines entering regulated and unregulated supply chains.
At the event, Acviss demonstrated serialization, track-and-trace, and product authentication technologies designed to help pharmaceutical brands improve traceability, secure packaging, verify authenticity, and strengthen patient trust across the supply chain.
Acviss at This Event
Event Gallery
Moments from the Event Floor
Event Video
Highlights from Pharma India Expo 2024
Conversations, demos, and insights from Acviss at Pharma India Expo 2024 focused on serialization, product authentication, and pharmaceutical supply chain protection.
Event Context
About The Pharma India Expo 2024
Event Scale & Reach
Pharma India Expo brings together pharmaceutical manufacturers, packaging providers, supply chain leaders, and healthcare technology companies focused on improving pharmaceutical safety and compliance.
Industry Focus
The event focuses on pharmaceutical manufacturing, packaging, serialization, anti-counterfeiting, regulatory compliance, and supply chain traceability.
Strategic Importance
The expo enabled Acviss to engage directly with pharmaceutical brands and manufacturers seeking secure serialization and product authentication systems to prevent counterfeit medicines.
What Industry Leaders Are Discussing
Key pharmaceutical safety, compliance, and traceability challenges highlighted by brands, manufacturers, and regulators.
Pharmaceutical brands increasingly require end-to-end serialization and traceability systems to improve visibility across manufacturing, warehousing, and distribution networks.
Counterfeit medicines continue to pose major risks to patient safety, making product authentication and secure packaging critical priorities for pharmaceutical companies.
Governments and healthcare regulators are strengthening pharmaceutical serialization and compliance requirements to improve transparency and reduce counterfeit risks.
Counterfeit medicines are not only a brand protection issue. They directly affect patient safety, regulatory trust, and the integrity of the pharmaceutical supply chain.
Secure Your Pharmaceutical Supply Chain with Acviss
Explore serialization, product authentication, track-and-trace, and counterfeit detection solutions built for pharmaceutical brands.
